Trials / Completed
CompletedNCT02941120
Non-interventional Study With NOVOCART® Inject in the Reconstruction of the Knee Cartilage Defects
Retrospective Observational Study for Reconstruction of Localized, Full-thickness Cartilage Defects in the Knee Joint With In-situ Polymerizable and Chondrocyte Populated Biomaterial (NOVOCART® Inject)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 245 (actual)
- Sponsor
- Tetec AG · Industry
- Sex
- All
- Age
- 14 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Retrospective non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with full-thickness cartilage defects in the knee joint.
Detailed description
Retrospective and multicenter non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with localized full-thickness cartilage defects in the knee joint. Safety: Measuring the number of adverse drug reactions/serious adverse drug reactions since treatment and up to the present time. Efficacy: Evaluate symptoms and functional status at the present time using IKDC 2000 (International Knee Documentation Committee) and KOOS (Knee injury osteoarthritis outcome score).
Conditions
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2019-05-01
- Completion
- 2019-05-01
- First posted
- 2016-10-21
- Last updated
- 2019-12-03
Locations
7 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02941120. Inclusion in this directory is not an endorsement.